Institutional investors purchased a net $1.4 million shares of NUVA during the quarter ended June 2016 and now own 105.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 1.2 Million shares of NuVasive Inc